Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Pfizer readies four OTC drug brands for U.K. launch

Article Abstract:

Pfizer plans to double its sales of OTC medicines across the world to $1 billion by 2000, and as part of this strategy will probably launch OTC versions of a number of its prescription medicines in the UK during 1995. It is seeking a UK licence for an OTC version of its Feldene anti-arthritic drug, and hopes to launch the product in summer 1995 as an OTC topical analgesic. It has already received provisional approval for OTC versions of Atarax, an itching remedy, Diflucan, which treats vaginal thrush, and Combantin, which treats threadworms.

Publisher: Crain Communications, Inc.
Publication Name: Euromarketing
Subject: Business, international
ISSN: 0952-3820
Year: 1995
Product information, Pfizer Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Denmark launches two investigations of OTC industry

Article Abstract:

Investigations ordered by the Danish Ministry of Health are under way into the purchasing and marketing practices of the country's over-the-counter drugs industry. One enquiry has been prompted by allegations from Danish consumer groups that Danmarks Apotekerforening (DAF), the Danish retail pharmacy association, may be contravening European Union competition rules. DAF's agreement with wholesale drugs firms requires OTC suppliers to reduce prices or their products will be removed from pharmacy shelves.

Publisher: Crain Communications, Inc.
Publication Name: Euromarketing
Subject: Business, international
ISSN: 0952-3820
Year: 1995
Denmark, Laws, regulations and rules, Marketing

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Bayer aligns $250m global account with BBDO

Article Abstract:

Bayer AG has awarded its worldwide advertising account for consumer products to advertising agency BBDO. The account, said to be worth up to $285 million a year, will include all Bayer's consumer pharmaceutical products, such as Alka-Seltzer, Bayer Aspirin and Canestan. Bayer's media buying will continue to be on a country-by-country basis.

Publisher: Crain Communications, Inc.
Publication Name: Euromarketing
Subject: Business, international
ISSN: 0952-3820
Year: 1995
Advertising agencies, Contracts, Advertising, Bayer AG, BBDO Worldwide Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Pharmaceutical industry, Proprietary drugs, Nonprescription drugs
Similar abstracts:
  • Abstracts: Technological externalities and economies of vertical integration in the electric utility industry. Price wars and collusion in the Spanish electricity market
  • Abstracts: BBVA withdraws from the battle to acquire BNL. Danske Bank agrees to buy Sampo operations for $5.15 billion. BNP Paribas buys Libya bank stake
  • Abstracts: Could a mineral deficiency be holding you back? Quick ways to turn off tiredness. Alert! Silent sinus trouble linked to tiredness
  • Abstracts: LP relaxation of the two dimensional knapsack problem with box and GUB constraints. Neighborhood search heuristics for the uncapacitated facility location problem
  • Abstracts: Malaysia sets plan to lure funds, open its capital markets. Smaller currency markets could yield big returns. Berjaya unit seeks to void big derivatives transaction
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.